LY3437943
| Classification | Synthetic triple receptor agonist peptide (GIP / GLP-1 / glucagon) |
|---|---|
| CAS number | 2381089-83-2 |
| Solubility | Soluble in water and bacteriostatic water. |
| Reported half-life | Engineered for extended duration relative to native incretin peptides; reported values come from clinical pharmacokinetic studies. |
International orders have a 3-vial minimum per product. Case pricing shown is international; US warehouse case pricing may differ and is shown at checkout.
An investigational single-molecule agonist at the GIP, GLP-1, and glucagon receptors, developed by Eli Lilly and identified in the literature as LY3437943. It remains an investigational compound and is not an approved medicine.
The following describes contexts in which this compound appears in published laboratory literature. Nothing here is a claim of efficacy, safety, or suitability for any use in humans or animals.
| Lyophilized powder | Store lyophilized powder at -20 °C, sealed and protected from light. Stable for extended periods while dry. |
|---|---|
| After reconstitution | After reconstitution with bacteriostatic water, store at 2–8 °C and use within approximately 4 weeks. Avoid repeated freeze-thaw cycles. |
| Shipping | Ships at ambient temperature; lyophilized peptide is stable in transit. |
Open reconstitution calculator →
| Vial | 1 vial (US) | 3 vials (Intl) | Case of 5 | Case of 10 | Stock |
|---|---|---|---|---|---|
| 10mg | $75 | $210 | $275 | $400 | 5 in Denver |
| 20mg | $95 | $270 | $315 | $360 | 8 in Denver |
| 30mg | — | $300 | $395 | $580 | International |
| 60mg | $180 | $450 | $500 | $800 | 10 in Denver |
$20 flat USA shipping · solutioning available at $10/vial · Denver stock ships within 1 business day of order confirmation.